biospecimen__admin__batch_number	304.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	6
biospecimen__admin__dbgap_registration_code	000178
biospecimen__admin__disease_code	ACC
biospecimen__admin__file_uuid	12675D5E-4D00-44DE-A05A-FB900D1424AC
biospecimen__admin__month_of_dcc_upload	11
biospecimen__admin__program	TCGA
biospecimen__admin__year_of_dcc_upload	2018
biospecimen__bio__bcr_analyte_barcode	TCGA-OR-A5J8-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-OR-A5J8-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-OR-A5J8-01A
biospecimen__bio__biospecimen_barcode_bottom	0145632215
biospecimen__bio__day_of_creation	25
biospecimen__bio__day_of_shipment	08
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-OR-A5J8.EA68CD7A-9308-40CD-BB52-CEB36334A146.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A29S
biospecimen__bio__plate_row	G
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	2.21
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-OR-A5J8
biospecimen__shared__patient_id	A5J8
clinical__acc_shared__atypical_mitotic_figures	Atypical Mitotic Figures Present
clinical__acc_shared__cytoplasm_presence_less_than_equal_25_percent	Cytoplasm presence <= 25% Present
clinical__acc_shared__diffuse_architecture	Diffuse Architecture Present
clinical__acc_shared__excess_adrenal_hormone_diagnosis_method_type	Biochemical Assessment
clinical__acc_shared__excess_adrenal_hormone_history_type	Cortisol
clinical__acc_shared__invasion_of_tumor_capsule	Invasion of Tumor Capsule Present
clinical__acc_shared__mitoses_count	15
clinical__acc_shared__mitotane_therapy	YES
clinical__acc_shared__mitotane_therapy_adjuvant_setting	YES
clinical__acc_shared__mitotic_rate	Mitotic Rate > 5/50 HPF Present
clinical__acc_shared__necrosis	Necrosis Present
clinical__acc_shared__nuclear_grade_iii_iv	Nuclear Grade III or IV Present
clinical__acc_shared__sinusoid_invasion	Sinusoid Invasion Absent
clinical__acc_shared__therapeutic_mitotane_levels_achieved	NO
clinical__acc_shared__therapeutic_mitotane_lvl_recurrence	NO
clinical__acc_shared__weiss_score	8
clinical__acc_shared__weiss_venous_invasion	Venous Invasion Present
clinical__admin__batch_number	304.64.0
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	4055C8C3-1ED4-4BF6-A56F-EBCCDC14A665
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__admin__year_of_dcc_upload	2016
clinical__clin_shared__age_at_initial_pathologic_diagnosis	66
clinical__clin_shared__ct_scan	YES
clinical__clin_shared__ct_scan_findings	Normal
clinical__clin_shared__day_of_form_completion	3
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__laterality	Left
clinical__clin_shared__lymph_node_examined_count	1
clinical__clin_shared__month_of_form_completion	12
clinical__clin_shared__number_of_lymphnodes_positive_by_he	0
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__post_surgical_procedure_assessment_thyroid_gland_carcinoma_status	No imaging evidence of disease
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__primary_lymph_node_presentation_assessment	YES
clinical__clin_shared__primary_therapy_outcome_success	Complete Remission/Response
clinical__clin_shared__radiation_therapy	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Adrenal
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	YES
clinical__nte__days_to_new_tumor_event_after_initial_treatment	530
clinical__nte__new_neoplasm_confirmed_diagnosis_method_name	Imaging
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Peritoneal Surfaces
clinical__nte__new_neoplasm_event_type	Locoregional Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rad__anatomic_treatment_site	Primary Tumor Field
clinical__rad__bcr_radiation_barcode	TCGA-OR-A5J8-R54360
clinical__rad__bcr_radiation_uuid	ACC50D7D-5B8F-4187-A636-D087B2AD8DD0
clinical__rad__days_to_radiation_therapy_end	138
clinical__rad__days_to_radiation_therapy_start	107
clinical__rad__numfractions	25
clinical__rad__radiation_dosage	4500
clinical__rad__radiation_treatment_ongoing	NO
clinical__rad__radiation_type	External
clinical__rad__units	cGy
clinical__shared__germline_testing_performed	YES
clinical__shared__histological_type	Adrenocortical carcinoma- Usual Type
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__other_dx	No
clinical__shared_stage__clinical_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3
gcm_curated__age	24266
gcm_curated__alt_biosample_source_id	TCGA-OR-A5J8-01A
gcm_curated__alt_donor_source_id	TCGA-OR-A5J8
gcm_curated__alt_item_source_id	TCGA-OR-A5J8-01A-11R-A29S-07
gcm_curated__assembly	GRCh38
gcm_curated__biological_replicate_count	1
gcm_curated__biological_replicate_number	1
gcm_curated__biosample_source_id	2f47f06e-8f76-440e-bbce-b7c90635a59e
gcm_curated__biosample_type	tissue
gcm_curated__case_source_id	08e0d412-d4d8-4d13-b792-a4dd0bd9ec2b
gcm_curated__checksum	59eb2e710458bd3005b12a39ee82b387
gcm_curated__data_type	Gene Expression Quantification
gcm_curated__dataset_name	GRCh38_TCGA_gene_expression_2019_10
gcm_curated__date	2019-09-12T10:50:43.000000+02:00
gcm_curated__disease	Adrenocortical Carcinoma
gcm_curated__donor_source_id	08e0d412-d4d8-4d13-b792-a4dd0bd9ec2b
gcm_curated__ethnicity	white
gcm_curated__external_reference	https://portal.gdc.cancer.gov/cases/08e0d412-d4d8-4d13-b792-a4dd0bd9ec2b
gcm_curated__feature	gene expression
gcm_curated__file_format	BED
gcm_curated__file_name	73fee5d0-d326-484c-95c6-c40c987c6917-geq.bed
gcm_curated__gender	male
gcm_curated__is_annotation	false
gcm_curated__is_healthy	false
gcm_curated__item_source_id	73fee5d0-d326-484c-95c6-c40c987c6917-geq
gcm_curated__local_url	http://www.gmql.eu/gmql-rest/datasets/public.GRCh38_TCGA_gene_expression_2019_10/73fee5d0-d326-484c-95c6-c40c987c6917-geq/region
gcm_curated__pipeline	HTSeq - Counts, HTSeq - FPKM, HTSeq - FPKM-UQ
gcm_curated__project_name	TCGA-ACC
gcm_curated__replicate_source_id	2f47f06e-8f76-440e-bbce-b7c90635a59e
gcm_curated__size	5135072
gcm_curated__source	TCGA
gcm_curated__source_page	https://portal.gdc.cancer.gov/files/1482d80c-478e-4b74-bb94-444e1b14243c,https://portal.gdc.cancer.gov/files/cedcf952-a097-49df-a0b2-d13cb9dead57,https://portal.gdc.cancer.gov/files/bc11ef70-0de9-493a-8c7d-113213b60198
gcm_curated__source_site	University of Michigan
gcm_curated__source_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/73fee5d0-d326-484c-95c6-c40c987c6917-geq.bed
gcm_curated__species	Homo sapiens
gcm_curated__technical_replicate_count	1
gcm_curated__technical_replicate_number	1_1
gcm_curated__technique	RNA-Seq
gcm_curated__tissue	Adrenal gland
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	73fee5d0-d326-484c-95c6-c40c987c6917
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-OR-A5J8-01A-11R-A29S-07
gdc__aliquots__updated_datetime	2018-11-28T09:13:25.063015-06:00
gdc__analysis__analysis_id	47085b65-80c3-4cbc-869c-1388e098998e,c6acc849-c921-4ba0-a951-78b1f4444475,8c82aaca-a32f-4841-b874-dffc881e426f
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM-UQ,HTSeq - FPKM
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	032b91cf-c655-4eba-b204-e8e70c47b95d
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__concentration	0.17
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	08e0d412-d4d8-4d13-b792-a4dd0bd9ec2b
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-26T21:09:32.933061-05:00,2016-05-26T21:09:33.105453-05:00,2016-05-26T21:09:33.351418-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__age_at_index	66
gdc__demographic__days_to_birth	-24266
gdc__demographic__days_to_death	579
gdc__demographic__demographic_id	c7ee293d-87da-5a5a-9121-6963a2a36b25
gdc__demographic__ethnicity	hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__vital_status	Dead
gdc__demographic__year_of_birth	1945
gdc__demographic__year_of_death	2012
gdc__diagnoses__age_at_diagnosis	24266
gdc__diagnoses__ajcc_clinical_m	M0
gdc__diagnoses__ajcc_pathologic_n	N0
gdc__diagnoses__ajcc_pathologic_t	T3
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_diagnosis	0
gdc__diagnoses__diagnosis_id	aa898338-0a98-5a3c-a7a7-64e8ca006407
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8370/3
gdc__diagnoses__primary_diagnosis	Adrenal cortical carcinoma
gdc__diagnoses__prior_malignancy	no
gdc__diagnoses__prior_treatment	No
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Cortex of adrenal gland
gdc__diagnoses__tissue_or_organ_of_origin	Cortex of adrenal gland
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iii
gdc__diagnoses__year_of_diagnosis	2011
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__alcohol_history	Not Reported
gdc__exposures__exposure_id	1fc49e34-3ffe-5e3b-9430-3bf99b25cc69
gdc__file_id	1482d80c-478e-4b74-bb94-444e1b14243c,cedcf952-a097-49df-a0b2-d13cb9dead57,bc11ef70-0de9-493a-8c7d-113213b60198
gdc__file_name	d79cc425-b0d5-4d6f-9254-9b6d3d1b86d8.htseq.counts.gz,d79cc425-b0d5-4d6f-9254-9b6d3d1b86d8.FPKM-UQ.txt.gz,d79cc425-b0d5-4d6f-9254-9b6d3d1b86d8.FPKM.txt.gz
gdc__file_size	252521,519415,517542
gdc__input_files__access	controlled
gdc__input_files__data_category	Sequencing Reads
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__file_id	bd2004e3-31de-483f-b26f-bd9c718e2e3b
gdc__input_files__file_name	919dbe0a-7c3d-4ca7-83d4-1e7060faf2d7_gdc_realn_rehead.bam
gdc__input_files__file_size	7659609017
gdc__input_files__md5sum	0d1038b90b68b8675d231a37b8f63d92
gdc__input_files__platform	Illumina
gdc__md5sum	786542023b1a02a99d49c690aed1b327,9aee21333df14268e36bcb976f19a910,99a69aa7cba9e910cd55916d026c668c
gdc__portions__is_ffpe	false
gdc__portions__portion_id	20e1679e-c463-44fc-939c-1edff3057e08
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Adrenal gland
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Adrenocortical Carcinoma
gdc__project__project_id	TCGA-ACC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	396
gdc__samples__initial_weight	160.0
gdc__samples__is_ffpe	false
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	EA68CD7A-9308-40CD-BB52-CEB36334A146
gdc__samples__sample_id	2f47f06e-8f76-440e-bbce-b7c90635a59e
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__samples__tissue_type	Not Reported
gdc__slides__percent_lymphocyte_infiltration	4.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	87e81eca-ce5e-4839-8840-4937743a70dc
gdc__submitter_id	d79cc425-b0d5-4d6f-9254-9b6d3d1b86d8_count,d79cc425-b0d5-4d6f-9254-9b6d3d1b86d8_uqfpkm,d79cc425-b0d5-4d6f-9254-9b6d3d1b86d8_fpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	OR
gdc__tissue_source_site__name	University of Michigan
gdc__tissue_source_site__tissue_source_site_id	2ff9cebf-b83f-5ec2-aae4-3aa1bf1bb02d
gdc__treatments__treatment_id	d1e4f8c7-2c22-5a06-b910-634d296b4028
gdc__treatments__treatment_or_therapy	yes
gdc__treatments__treatment_type	Radiation Therapy, NOS,Radiation Therapy, NOS
gdc__type	gene_expression
gdc__updated_datetime	2019-09-18T14:38:42.659845+00:00
manually_curated__data_format	BED
manually_curated__download_date	2019-11-05T21:19:22.933+01:00
manually_curated__exp_data_bed_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/73fee5d0-d326-484c-95c6-c40c987c6917-geq.bed
manually_curated__exp_metadata_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/73fee5d0-d326-484c-95c6-c40c987c6917-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5135073
manually_curated__local_md5	c8b019dc9b8ca0d45982df1eae42e8f1
manually_curated__opengdc_download_date	2019-09-12T10:50:43.000000+02:00
manually_curated__opengdc_file_md5	59eb2e710458bd3005b12a39ee82b387
manually_curated__opengdc_file_size	5135072
manually_curated__opengdc_id	73fee5d0-d326-484c-95c6-c40c987c6917-geq
manually_curated__origin_file_size	5135072
manually_curated__origin_last_modified_date	Mon Sep 30 16:52:00 CEST 2019
manually_curated__origin_md5	59eb2e710458bd3005b12a39ee82b387
manually_curated__tissue_status	tumoral
